Intravenous Infusions (XGHA:IIL) EV-to-FCF : (As of Sep. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Intravenous Infusions's Enterprise Value is GHS0.00 Mil. Intravenous Infusions does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Intravenous Infusions's EV-to-FCF at this moment.

The historical rank and industry rank for Intravenous Infusions's EV-to-FCF or its related term are showing as below:

XGHA:IIL's EV-to-FCF is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 22.47
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-21), Intravenous Infusions's stock price is GHS0.05. Intravenous Infusions does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Intravenous Infusions's PE Ratio at this moment.

Intravenous Infusions EV-to-FCF Historical Data

The historical data trend for Intravenous Infusions's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions EV-to-FCF Chart

Intravenous Infusions Annual Data

Trend

EV-to-FCF

Intravenous Infusions Semi-Annual Data

EV-to-FCF

Competitive Comparison of Intravenous Infusions's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's EV-to-FCF falls into.

Intravenous Infusions EV-to-FCF Calculation

Intravenous Infusions's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	0.000	/
	=

Intravenous Infusions (XGHA:IIL) EV-to-FCF Explanation

Intravenous Infusions's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.05	/
	=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Intravenous Infusions EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » EV-to-FCF

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.